You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 21, 2025

Details for Patent: 11,234,946


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,234,946
Title:Bupropion as a modulator of drug activity
Abstract: Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
Inventor(s): Tabuteau; Herriot (New York, NY)
Assignee: ANTECIP BIOVENTURES II LLC (New York, NY)
Application Number:17/092,968
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 11,234,946

Introduction

When analyzing a U.S. patent, it is crucial to understand the scope and claims that define the intellectual property protected by the patent. This article will delve into the key aspects of patent analysis, using United States Patent 11,234,946 as a case study. We will explore the patent landscape, the role of the U.S. Patent and Trademark Office (USPTO), and the intricacies of patent claims.

The Role of the U.S. Patent and Trademark Office (USPTO)

The USPTO is the agency responsible for granting U.S. patents and registering trademarks. It plays a pivotal role in ensuring that patents are granted to inventions that meet the criteria of novelty, non-obviousness, and usefulness[1].

Patent Landscape Overview

The patent landscape in the United States is complex and dynamic. It involves a vast array of patents across various technologies and industries. The USPTO receives and processes thousands of patent applications annually, each with its unique set of claims and specifications[2].

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of protection granted to the inventor. They must be clear, concise, and supported by the patent's description and drawings. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit an independent claim[3].

Independent Claims

Independent claims are crucial as they define the broadest scope of the invention. These claims must be novel and non-obvious over the prior art. For example, in the case of Gilbert P. Hyatt, his applications included a large number of independent claims, each requiring distinct subject matter to avoid prosecution laches and other validity issues[2].

Dependent Claims

Dependent claims build upon independent claims by adding additional limitations. These claims are often used to provide a fallback position in case the broader independent claims are found invalid. The dependent claims in Hyatt's applications, for instance, grew significantly over time, averaging 300 claims per application, which is far beyond the average number of claims in typical applications[2].

Patent Scope and Measurements

The scope of a patent is a critical factor in determining its validity and enforceability. The USPTO provides datasets and research tools to analyze patent scope, such as the Patent Claims Research Dataset. This dataset includes detailed information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. It helps in understanding the dependency relationships between claims and provides statistics on patent scope[3].

Obviousness-Type Double Patenting (ODP)

ODP is a significant issue in patent law that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA). The case of In re Cellect highlights the importance of ODP analysis in ensuring that patents do not unfairly extend their term[4].

Prosecution and Examination Process

The prosecution and examination process at the USPTO involves several stages, including initial review, examination, and potential appeals. Patent examiners evaluate the claims for novelty, non-obviousness, and written description. In cases like Hyatt's, where there are numerous claims and amendments, the process can be lengthy and complex. The Board of Patent Appeals and Interferences (now the Patent Trial and Appeal Board) plays a crucial role in resolving disputes and affirming or reversing examiner rejections[2].

Case Study: United States Patent 11,234,946

To analyze the scope and claims of United States Patent 11,234,946, one must start by reviewing the patent's specification and claims. Here are some key steps:

Reviewing the Specification

The specification provides a detailed description of the invention, including drawings and examples. It must support the claims and ensure that the invention is fully disclosed.

Analyzing the Claims

  • Independent Claims: Identify the independent claims and analyze their breadth and specificity.
  • Dependent Claims: Examine how the dependent claims further limit the independent claims.
  • Claim Language: Ensure the claims are clear and concise, avoiding ambiguity.

Evaluating Prior Art and Novelty

Compare the claims against prior art to ensure the invention is novel and non-obvious. This involves a thorough search of existing patents and publications.

Assessing Written Description and Enablement

Verify that the specification provides a written description of the invention and enables one skilled in the art to make and use the invention.

Key Takeaways

  • Patent Claims: The claims are the most critical part of a patent, defining the scope of protection.
  • USPTO Role: The USPTO is essential in ensuring patents meet the criteria of novelty, non-obviousness, and usefulness.
  • Patent Scope: Understanding patent scope involves analyzing claim dependencies and statistics.
  • ODP: Obviousness-Type Double Patenting prevents unfair extension of patent terms.
  • Prosecution Process: The examination and appeal process ensures that patents are valid and enforceable.

FAQs

What is the role of the USPTO in patent granting?

The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that patents meet the criteria of novelty, non-obviousness, and usefulness[1].

How do independent and dependent claims differ?

Independent claims define the broadest scope of the invention, while dependent claims further limit the independent claims by adding additional limitations[3].

What is Obviousness-Type Double Patenting (ODP)?

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of PTA[4].

How does the USPTO analyze patent scope?

The USPTO uses datasets like the Patent Claims Research Dataset to analyze patent scope, including claim dependencies and statistics[3].

What is the significance of the written description requirement in patent law?

The written description requirement ensures that the specification provides a clear and enabling description of the invention, allowing one skilled in the art to make and use it[5].

Sources

  1. U.S. Patent and Trademark Office (USPTO) | USAGov
  2. HYATT v. HIRSHFELD - Court of Appeals for the Federal Circuit
  3. Patent Claims Research Dataset - USPTO
  4. In re Cellect - United States Court of Appeals for the Federal Circuit
  5. 35 USC 282: Presumption of validity; defenses

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,234,946

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Axsome AUVELITY bupropion hydrochloride; dextromethorphan hydrobromide TABLET, EXTENDED RELEASE;ORAL 215430-001 Aug 18, 2022 RX Yes Yes 11,234,946 ⤷  Try for Free DEXTROMETHORPHAN AND BUPROPION IN COMBINATION TO TREAT MAJOR DEPRESSIVE DISORDER ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.